Alps Advisors Inc Emergent Bio Solutions Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$7.79 - $16.29 $6,247 - $13,064	-802 Reduced 2.37%	33,036 $342,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $72,897 - $142,149	6,627 Added 24.35%	33,838 $399,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $52,113 - $92,865	-2,594 Reduced 8.7%	27,211 $571,000
Q2 2022 Aug 11, 2022	SELL	$27.42 - $43.63 $605,982 - $964,223	-22,100 Reduced 42.58%	29,805 $925,000
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $377,750 - $540,738	-10,355 Reduced 16.63%	51,905 $2.13 Million
Q4 2021 Feb 09, 2022	SELL	$33.11 - $55.01 $117,838 - $195,780	-3,559 Reduced 5.41%	62,260 $2.71 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $405,567 - $535,005	-8,100 Reduced 10.96%	65,819 $3.3 Million
Q2 2021 Aug 11, 2021	SELL	$56.61 - $80.46 $1.45 Million - $2.06 Million	-25,607 Reduced 25.73%	73,919 $4.66 Million
Q1 2021 May 07, 2021	BUY	$86.23 - $125.19 $110,978 - $161,119	1,287 Added 1.31%	99,526 $9.25 Million
Q4 2020 Feb 03, 2021	BUY	$79.17 - $111.47 $2.23 Million - $3.13 Million	28,120 Added 40.1%	98,239 $8.8 Million
Q3 2020 Nov 04, 2020	SELL	$81.91 - $134.94 $114,592 - $188,781	-1,399 Reduced 1.96%	70,119 $7.25 Million
Q2 2020 Aug 05, 2020	BUY	$54.33 - $89.52 $3.89 Million - $6.4 Million	71,518 New	71,518 $5.66 Million
Q4 2019 Feb 07, 2020	SELL	$51.21 - $59.06 $5.27 Million - $6.08 Million	-102,901 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$40.6 - $57.2 $172,956 - $243,672	-4,260 Reduced 3.98%	102,901 $5.38 Million
Q2 2019 Aug 07, 2019	SELL	$39.92 - $53.86 $658,919 - $889,013	-16,506 Reduced 13.35%	107,161 $5.18 Million
Q1 2019 May 01, 2019	SELL	$48.23 - $66.16 $52,860 - $72,511	-1,096 Reduced 0.88%	123,667 $6.25 Million
Q4 2018 Feb 04, 2019	BUY	$55.63 - $73.24 $1.61 Million - $2.12 Million	28,929 Added 30.19%	124,763 $7.4 Million
Q3 2018 Oct 25, 2018	BUY	$52.05 - $66.51 $796,052 - $1.02 Million	15,294 Added 18.99%	95,834 $6.31 Million
Q2 2018 Aug 02, 2018	BUY	$48.33 - $55.64 $1.08 Million - $1.25 Million	22,446 Added 38.64%	80,540 $4.07 Million
Q2 2018 Jul 25, 2018	SELL	$48.33 - $55.64 $834,465 - $960,680	-17,266 Reduced 22.91%	58,094 $2.7 Million
Q1 2018 May 01, 2018	BUY	$44.44 - $54.39 $767,301 - $939,097	17,266 Added 29.72%	75,360 $3.97 Million
Q4 2017 Feb 05, 2018	BUY	$37.77 - $47.75 $199,538 - $252,263	5,283 Added 10.0%	58,094 $2.7 Million
Q3 2017 Nov 03, 2017	BUY	$34.14 - $40.45 $1.8 Million - $2.14 Million	52,811	52,811 $2.14 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account